home / stock / ards / ards news

ARDS News and Press, Aridis Pharmaceuticals Inc. From 09/30/19

Stock Information
Company Name: Aridis Pharmaceuticals Inc.
Stock Symbol: ARDS
Market: NASDAQ
Website: aridispharma.com
Menu
ARDS ARDS Quote ARDS Short ARDS News ARDS Articles ARDS Message Board
Get ARDS Alerts

News, Short Squeeze, Breakout and More Instantly...
ARDS - Aridis Pharmaceuticals Executes License Agreement with The Serum Institute of India, Ltd. for Exclusive Rights to Products and Utilization of MabIgX® Platform Technology

SAN JOSE, Calif. , Sept. 30, 2019 /PRNewswire/ --  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) , a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that it has consumma...
ARDS - Key events next week - healthcare

Noteworthy events during the week of September 29 - October 5 for healthcare investors. More news on: Capricor Therapeutics, Inc., Enanta Pharmaceuticals, Inc., ACADIA Pharmaceuticals Inc., Healthcare stocks news, , Read more ...

ARDS - Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium Citrate) Data at IDWeek(TM) 2019

SAN JOSE, Calif. , Sept. 27, 2019 /PRNewswire/ --  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today it will present two ...

ARDS - Aridis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference

SAN JOSE, Calif. , Sept. 27, 2019 /PRNewswire/ --  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that Vu Truong , Ph...
ARDS - CBL, GME, SATS, and ZS among midday movers

Gainers:  Yuma Energy (NYSEMKT: YUMA ) +145% . T2 Biosystems (NASDAQ: TTOO ) +57% . Lexicon Pharmaceuticals (NASDAQ: LXRX ) +29% . Bicycle Therapeutics (NASDAQ: BCYC ) +25% . CARBO Ceramics (NYSE: CRR ) +23% . Luby's (NYSE: LUB ) +23% . CBL & Associates Properties (NYSE: CBL...

ARDS - Aridis Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference on September 10, 2019

SAN JOSE, Calif. , Sept. 8, 2019 /PRNewswire/ --  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that Vu Truong , Ph....

ARDS - Aridis Pharma's AR-105 flunks mid-stage study; shares down 27% premarket

Ultra-thinly traded micro cap Aridis Pharmaceuticals (NASDAQ: ARDS ) slumps  27%  premarket on light volume in reaction an unsuccessful  Phase 2 clinical trial evaluating candidate AR-105, a fully human IgG1 monoclonal antibody, for the treatment of ventilator-associated pneu...
ARDS - Aridis Pharmaceuticals Reports Phase 2 Clinical Trial Results of AR-105 for the Treatment of Ventilator-Associated Pneumonia Caused by Pseudomonas Aeruginosa

SAN JOSE, Calif. , Sept. 3, 2019 /PRNewswire/ --  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) , a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today announced results from the Comp...

ARDS - Aridis Pharmaceuticals EPS misses by $0.11

Aridis Pharmaceuticals (NASDAQ: ARDS ): Q2 GAAP EPS of -$1.03 misses by $0.11 . Total cash and cash equivalents of $8.5M Press Release More news on: Aridis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,

ARDS - Aridis Pharmaceuticals Announces Second Quarter 2019 Results

SAN JOSE, Calif. , Aug. 12, 2019 /PRNewswire/ --  Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infectio...
Previous 10 Next 10